TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1971234

Group type: EXPERIMENTAL
Intervention: Chorionic villus sampling (CVS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amniocentesis
Number of subjects: 0
Study: 6138071

Group type: EXPERIMENTAL
Intervention: 15 mg midazolam
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1 tablet Vesparax (50 mg hydroxyzine, 150 mg secobarbital, 50 mg brallobarbital)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31996179

Group type: EXPERIMENTAL
Intervention: Adolescent-caregiver dyads reporting IPV and VAC
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Adolescent-caregiver dyads reporting IPV
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Female caregiver-adolescent dyads with both VAC and IPV
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Male caregiver-adolescent dyads with both VAC and IPV
Number of subjects: 535
Study: 31376801

Group type: EXPERIMENTAL
Intervention: Effective bilateral transcranial direct current stimulation (20 min, 2 mA)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sham bilateral transcranial direct current stimulation
Number of subjects: 13
Study: 28894070

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy for insomnia (CBT‐I) using mobile SNS, provided once a week for 60 minutes over six weeks
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 55
Study: 25918972

Group type: EXPERIMENTAL
Intervention: Combined treatment of donepezil and ninjin'yoeito (NYT)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Donepezil alone
Number of subjects: 23
Study: 24315962

Group type: EXPERIMENTAL
Intervention: Iron supplementation (ferric hydroxide-polymaltose complex, 6mg/kg Fe(3+)/day) for 1-6 months
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (35 infants)
Number of subjects: 65
Study: 23079898

Group type: EXPERIMENTAL
Intervention: High levels of neuroticism and extraversion
Number of subjects: 602

Group type: COMPARATOR
Intervention: Low levels of neuroticism and extraversion
Number of subjects: 602
Study: 19440890

Group type: EXPERIMENTAL
Intervention: Clinician-assisted Sadness programme (CaCCBT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 45
Study: 22108262

Group type: EXPERIMENTAL
Intervention: Conventional review plus an additional review looking for missing items from reporting guidelines (n=51)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Conventional reviews alone (n=41)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Conventional review suggestions adherence (n=51)
Number of subjects: 92
Study: 16410944

Group type: EXPERIMENTAL
Intervention: Motivational intervention (Group B)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Routine recommendations (Group A)
Number of subjects: 76
Study: 11845867

Group type: EXPERIMENTAL
Intervention: [1-deaminopenicillamine, 4-valine, 8-D-arginine] vasopressin
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Calcium-channel antagonists (nifedipine, diltiazem, verapamil)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Control (AVP-induced contraction)
Number of subjects: 218
Study: 10082500

Group type: EXPERIMENTAL
Intervention: Quinapril (daily dose titrated between 2.5 and 20 mg)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Atenolol (daily dose titrated between 12.5 and 100 mg)
Number of subjects: 59
Study: 7740014

Group type: EXPERIMENTAL
Intervention: Active nicotine patch + active gum (group 1)
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Active nicotine patch + placebo gum (group 2)
Number of subjects: 374

Group type: COMPARATOR
Intervention: Placebo patch + gum (group 3)
Number of subjects: 374
Study: 2344090

Group type: EXPERIMENTAL
Intervention: 1% povidone-iodine soak
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Normal saline soak
Number of subjects: 29

Group type: COMPARATOR
Intervention: No soak (control)
Number of subjects: 29
Study: 7362094

Group type: EXPERIMENTAL
Intervention: Inhaled diluent
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Methacholine
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Automated spirometry
Number of subjects: 2

Group type: COMPARATOR
Intervention: Body plethysmograph
Number of subjects: 2
Study: 29860057

Group type: EXPERIMENTAL
Intervention: Varenicline 1 mg BID
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 27521594

Group type: EXPERIMENTAL
Intervention: Acupuncture with fire needling on acupoint BL67
Number of subjects: 259

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 259
Study: 23834587

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Selective Serotonin Reuptake Inhibitor (SSRI)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy + SSRI (CBT+SSRI)
Number of subjects: 150
Study: 23184627

Group type: EXPERIMENTAL
Intervention: Granisetron
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 20036048

Group type: EXPERIMENTAL
Intervention: Inside-out transobturator tape (TVT-O)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Outside-in transobturator tape (ARIS)
Number of subjects: 341
Study: 18503531

Group type: EXPERIMENTAL
Intervention: Junior Detective Training Program (7-week program including a computer game, small group sessions, parent training sessions, and teacher handouts)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Junior Detective Training Program
Number of subjects: 49

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 49
Study: 15897160

Group type: EXPERIMENTAL
Intervention: Topical immunotherapy with squaric acid dibutylester (SADBE)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 54
Study: 12550076

Group type: EXPERIMENTAL
Intervention: MK-677 25mg daily
Number of subjects: 12
Study: 10506267

Group type: EXPERIMENTAL
Intervention: Erythromycin estolate (40 mg/kg/day in 3 divided doses; maximum dose 1 g) for 10 days
Number of subjects: 310

Group type: COMPARATOR
Intervention: Placebo for 10 days
Number of subjects: 310
Study: 8529510

Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 354

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 354
Study: 1952134

Group type: EXPERIMENTAL
Intervention: Intravenous metoclopramide (10 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 15
Study: 6119169

Group type: EXPERIMENTAL
Intervention: Oxatomide
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 31535510

Group type: EXPERIMENTAL
Intervention: Breastfeeding during BCG vaccination
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 100
Study: 27077238

Group type: EXPERIMENTAL
Intervention: Siblings Are Special (SIBS) intervention, 12 weekly afterschool sessions (90 min each) and 3 family nights (2 hr each)
Number of subjects: 54

Group type: COMPARATOR
Intervention: No-attention control
Number of subjects: 54
Study: 24708747

Group type: EXPERIMENTAL
Intervention: Option Grid
Number of subjects: 72

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 72
Study: 22592331

Group type: EXPERIMENTAL
Intervention: 8 min modified sham feeding (MSF) with 100 ml intragastrically infused liquid (isocaloric, 99 kcal, 100 ml/min)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 8 min modified sham feeding (MSF) with 800 ml intragastrically infused liquid (isocaloric, 99 kcal, 100 ml/min)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 1 min modified sham feeding (MSF) with 100 ml intragastrically infused liquid (isocaloric, 99 kcal, 100 ml/min)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 1 min modified sham feeding (MSF) with 800 ml intragastrically infused liquid (isocaloric, 99 kcal, 100 ml/min)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control condition (no oral or gastric stimulation)
Number of subjects: 26
Study: 19834718

Group type: EXPERIMENTAL
Intervention: Clomiphene 100 mg + delayed low dose gonadotropin + flexible GnRH antagonist administration
Number of subjects: 243

Group type: COMPARATOR
Intervention: GnRH agonist + gonadotropin
Number of subjects: 243
Study: 18599569

Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone (IVTA)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sham injections
Number of subjects: 43
Study: 16079209

Group type: EXPERIMENTAL
Intervention: BMI below 20
Number of subjects: 3110

Group type: EXPERIMENTAL
Intervention: BMI 20-22
Number of subjects: 3110

Group type: EXPERIMENTAL
Intervention: BMI 24
Number of subjects: 3110

Group type: EXPERIMENTAL
Intervention: BMI 22 for men and 20 for women
Number of subjects: 3110

Group type: EXPERIMENTAL
Intervention: Crude mortality rates
Number of subjects: 3110
Study: 12162754

Group type: EXPERIMENTAL
Intervention: HFA-BDP
Number of subjects: 473

Group type: COMPARATOR
Intervention: CFC-BDP
Number of subjects: 473
Study: 9717597

Group type: EXPERIMENTAL
Intervention: Rocuronium for non-smokers
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Rocuronium for smokers
Number of subjects: 40
Study: 7868405

Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239
Study: 2568848

Group type: EXPERIMENTAL
Intervention: Atracurium 1.1 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Atracurium 2.0 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vecuronium 0.25 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vecuronium 0.5 mg
Number of subjects: 40
Study: 781187

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31813104

Group type: EXPERIMENTAL
Intervention: McPhail traps with Bio Anastrepha® alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: McPhail traps with Bio Anastrepha® combined with different doses of insecticide
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 12
Study: 29113572

Group type: EXPERIMENTAL
Intervention: Individualized training instructions during 12 weeks (3×/week)
Number of subjects: 42
Study: 28319453

Group type: EXPERIMENTAL
Intervention: Vaccination education intervention
Number of subjects: 1252
Study: 25548124

Group type: EXPERIMENTAL
Intervention: Nurse-led problem-solving therapy (PST), 12 telephone-based sessions over 6 months.
Number of subjects: 254

Group type: COMPARATOR
Intervention: Usual care from primary care providers.
Number of subjects: 254
Study: 22406837

Group type: EXPERIMENTAL
Intervention: Fish diet
Number of subjects: 14

Group type: COMPARATOR
Intervention: Vegetarian diet
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Meat diet
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Half-meat-half-fish diet
Number of subjects: 14
Study: 21833720

Group type: EXPERIMENTAL
Intervention: RP101 (Brivudine) at a dose of 500 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RP101 (Brivudine) at a dose of 760 mg/day
Number of subjects: 0
Study: 18484984

Group type: EXPERIMENTAL
Intervention: D1 (1% chloramine T)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: D2 (0.01% fluorosurfactant)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 60
Study: 16713432

Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg plus HRT (conjugated equine estrogen 0.625 mg, medroxyprogesterone 5 mg, elemental calcium 500 mg)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg plus HRT
Number of subjects: 151

Group type: COMPARATOR
Intervention: HRT only
Number of subjects: 151
Study: 14656750

Group type: EXPERIMENTAL
Intervention: Information delivered by junior physicians
Number of subjects: 220

Group type: COMPARATOR
Intervention: Information delivered by senior physicians
Number of subjects: 220
Study: 11703474

Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan 6 mg
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 9738550

Group type: EXPERIMENTAL
Intervention: Clinic-based intervention (CB)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Home-based intervention (HB)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (delayed-treatment)
Number of subjects: 67
Study: 7981929

Group type: EXPERIMENTAL
Intervention: 75 mg resin‐bound diclofenac (resinate)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Enteric‐coated tablets containing 75 mg of diclofenac
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both treatments (resinate and enteric-coated tablets)
Number of subjects: 16
Study: 2689506

Group type: EXPERIMENTAL
Intervention: 100mg Mifepristone (RU 486) given morning and evening for 48 hours
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31522953

Group type: EXPERIMENTAL
Intervention: Discharge education designed according to the Model of Living
Number of subjects: 144
Study: 29932814

Group type: EXPERIMENTAL
Intervention: Neonatal vitamin A supplementation
Number of subjects: 306
Study: 27513920

Group type: EXPERIMENTAL
Intervention: Fracture reduction plus application of autologous mesenchymal stem cells (AMSCs)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fracture reduction only (Control)
Number of subjects: 20
Study: 26312886

Group type: EXPERIMENTAL
Intervention: Any form of image guidance (triplanar display, always-on solid overlay, always-on wire mesh overlay, on-demand inverse realism overlay)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Augmented reality systems (always-on wire mesh, on-demand inverse realism)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Always-on solid overlay
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Wire mesh and on-demand overlays
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Wire mesh and inverse realism overlays
Number of subjects: 50

Group type: COMPARATOR
Intervention: No image guidance
Number of subjects: 50

Group type: COMPARATOR
Intervention: Triplanar display
Number of subjects: 50
Study: 24039173

Group type: EXPERIMENTAL
Intervention: Genetic variants in ADAMTS16
Number of subjects: 2246

Group type: EXPERIMENTAL
Intervention: Psychiatric symptom severity
Number of subjects: 2246
Study: 21505058

Group type: EXPERIMENTAL
Intervention: Low-dose epoetin-β (35 IU/kg body weight, subcutaneously once weekly for 6 months)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Low-dose epoetin-β
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups (EPO and placebo)
Number of subjects: 24
Study: 18261731

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 79
Study: 17056812

Group type: EXPERIMENTAL
Intervention: Carotenoid-rich soups and beverages
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control vegetable soups and beverages
Number of subjects: 0
Study: 11791154

Group type: EXPERIMENTAL
Intervention: High-carbohydrate preload (1 MJ)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-fat preload (1 MJ)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Habitual meal frequency
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Manipulated meal frequency
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Macronutrient composition
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Blood glucose declines
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sweetness perception and hunger suppression
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Average baseline blood glucose levels
Number of subjects: 20
Study: 10470699

Group type: EXPERIMENTAL
Intervention: LVAD
Number of subjects: 78

Group type: COMPARATOR
Intervention: Medical management (controls)
Number of subjects: 78
Study: 7484039

Group type: EXPERIMENTAL
Intervention: esmolol 2 mg.kg‐1
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: esmolol 3 mg.kg‐1
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: alfentanil 0.03 mg.kg‐1
Number of subjects: 59

Group type: COMPARATOR
Intervention: saline
Number of subjects: 59
Study: 2150022

Group type: EXPERIMENTAL
Intervention: 840 mg stepronin, twice daily for 30 days
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 6252641

Group type: EXPERIMENTAL
Intervention: Conjugated equine oestrogen (Premarin) and medrogestone (Colpro)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Clonidine (Dixarit)
Number of subjects: 23
Study: 6131760

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 34

Group type: COMPARATOR
Intervention: Propranolol and Metoprolol
Number of subjects: 34
Study: 29578647

Group type: EXPERIMENTAL
Intervention: Gliclazide MR (Ranbaxy Laboratories Limited)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Diamicron MR (Servier)
Number of subjects: 48
Study: 29970156

Group type: EXPERIMENTAL
Intervention: Telephone interview administration of PROM
Number of subjects: 808

Group type: EXPERIMENTAL
Intervention: Postal questionnaire administration of PROM
Number of subjects: 808

Group type: EXPERIMENTAL
Intervention: Online questionnaire administration of PROM
Number of subjects: 808

Group type: COMPARATOR
Intervention: Face-to-face interview administration of PROM
Number of subjects: 808
Study: 27884360

Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon (DCB) angioplasty
Number of subjects: 181

Group type: COMPARATOR
Intervention: Standard Percutaneous Transluminal Angioplasty (PTA)
Number of subjects: 181
Study: 25350119

Group type: EXPERIMENTAL
Intervention: rectally applied tenofovir 1% gel
Number of subjects: 18
Study: 22992963

Group type: EXPERIMENTAL
Intervention: Silicone LMA-C
Number of subjects: 140

Group type: COMPARATOR
Intervention: PVC-based extra glottic airway devices
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: All devices
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Cobra group
Number of subjects: 140
Study: 21219785

Group type: EXPERIMENTAL
Intervention: Prospective ECG-triggered spiral scan
Number of subjects: 60

Group type: COMPARATOR
Intervention: Prospective ECG-triggered sequential scan
Number of subjects: 60
Study: 18808621

Group type: EXPERIMENTAL
Intervention: Body-mind-spirit group therapy (10 sessions, 180 minutes each)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 28
Study: 16160590

Group type: EXPERIMENTAL
Intervention: Fenofibrate 200 mg
Number of subjects: 112

Group type: COMPARATOR
Intervention: General measures (Control)
Number of subjects: 112
Study: 11801708

Group type: EXPERIMENTAL
Intervention: 89Sr plus 50 mg/m(2) cisplatin
Number of subjects: 70

Group type: COMPARATOR
Intervention: 89Sr plus placebo
Number of subjects: 70
Study: 10395624

Group type: EXPERIMENTAL
Intervention: Inulin (18 g/d)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (similar foods without inulin)
Number of subjects: 21
Study: 8788865

Group type: EXPERIMENTAL
Intervention: Mentally simulated actions in a virtual reality environment
Number of subjects: 15
Study: 1968126

Group type: EXPERIMENTAL
Intervention: New bedding constructed with a vapour‐permeable waterproof fabric that is impermeable to house dust mite antigen (Der p1).
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control samples from mattresses cleaned conventionally.
Number of subjects: 0
Study: 6987291

Group type: EXPERIMENTAL
Intervention: Ragweed pollen extract (0.53 ml of 1:312,500 w/v, mean cumulative dose of 0.094 micrograms of ragweed AgE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (administered by the Rinkel method)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ragweed pollen extract
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31525083

Group type: EXPERIMENTAL
Intervention: Ultrathin-strut BP-SES (60 μm)
Number of subjects: 1234

Group type: COMPARATOR
Intervention: Thin-strut DP-EES (81 μm)
Number of subjects: 1234
Study: 29166182

Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC) education
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no KMC education)
Number of subjects: 26
Study: 26440516

Group type: EXPERIMENTAL
Intervention: Calcium and Vitamin D (1g calcium/400IU vitamin D daily)
Number of subjects: 36282

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36282

Group type: COMPARATOR
Intervention: WHI Observational Study (WHI OS)
Number of subjects: 36282
Study: 23999278

Group type: EXPERIMENTAL
Intervention: Diabetes self-management intervention
Number of subjects: 238
Study: 21505367

Group type: EXPERIMENTAL
Intervention: Community-based follow-up care plus cereal-based supplementary food (C-SF)
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Community-based follow-up care plus psychosocial stimulation (C-PS)
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Community-based follow-up care plus both cereal-based supplementary food and psychosocial stimulation (C-SF + PS)
Number of subjects: 507

Group type: COMPARATOR
Intervention: Community-based follow-up care (C-C)
Number of subjects: 507

Group type: COMPARATOR
Intervention: Hospital-based follow-up care (H-C)
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Community-based follow-up care with supplementary food (SF)
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Community-based follow-up care
Number of subjects: 507
Study: 20439550

Group type: COMPARATOR
Intervention: Navy beans canned in Canada or UK, homemade navy beans, 300 ml glucose drink (50 g available carbohydrate)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Canned navy beans in tomato sauce, maple style, with pork and molasses, homemade navy beans with pork and molasses
Number of subjects: 43

Group type: COMPARATOR
Intervention: 4 equicaloric (300-kcal) treatments of pulses
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Navy beans
Number of subjects: 43

Group type: COMPARATOR
Intervention: White bread
Number of subjects: 43

Group type: COMPARATOR
Intervention: Glucose drink, white bread
Number of subjects: 43
Study: 17516492

Group type: EXPERIMENTAL
Intervention: Bright light therapy (BLT) for 15 days, 30 min daily at 7,500 lux
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo treatment for 15 days, 30 min daily at 950 lux
Number of subjects: 36
Study: 15248924

Group type: EXPERIMENTAL
Intervention: IFN‐alpha plus THP
Number of subjects: 68

Group type: COMPARATOR
Intervention: THP
Number of subjects: 68